SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-142257
Filing Date
2021-11-22
Accepted
2021-11-22 08:52:10
Documents
14
Period of Report
2021-11-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2133612d1_8k.htm   iXBRL 8-K 44979
2 EXHIBIT 3.1 tm2133612d1_ex3-1.htm EX-3.1 7090
3 EXHIBIT 3.2 tm2133612d1_ex3-2.htm EX-3.2 94546
  Complete submission text file 0001104659-21-142257.txt   344525

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xlrn-20211119.xsd EX-101.SCH 3046
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xlrn-20211119_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xlrn-20211119_pre.xml EX-101.PRE 22373
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2133612d1_8k_htm.xml XML 3587
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 211430283
SIC: 2836 Biological Products, (No Diagnostic Substances)